Neurofibrosarcoma is a rare and aggressive type of cancer that develops in the protective layers surrounding nerves throughout the body. While uncommon in the general population, it can affect people of all ages, particularly those with certain genetic conditions, and presents unique challenges that require specialized medical attention.

Understanding Neurofibrosarcoma

Neurofibrosarcoma, now more commonly known as malignant peripheral nerve sheath tumor (MPNST), is a cancer that forms in the soft tissues surrounding the peripheral nerves. These peripheral nerves are the ones that carry messages between your brain and spinal cord and the rest of your body, helping you move voluntarily and feel sensations. The tumors develop when cells that make up the nerve’s protective covering, called the nerve sheath, begin to grow abnormally and become cancerous.^[1]

These tumors are most commonly found in the arms and legs, although they can appear anywhere in the body where peripheral nerves exist. This includes the head, neck, chest, abdomen, pelvis, and back. What makes neurofibrosarcoma particularly challenging is its aggressive nature—the cancer grows quickly and can spread extensively along the nerve tissue itself.^[3]

The condition has been known by several different names over the years, including malignant schwannoma, malignant neurofibroma, and neurogenic sarcoma. Today, medical professionals prefer the term malignant peripheral nerve sheath tumor, or MPNST, to describe this type of cancer.^[6]

How Common Is This Cancer?

Neurofibrosarcoma is extremely rare. Doctors diagnose only about 200 cases per year in the United States, making it one of the less common cancers people face.^[6] When looking at all soft tissue sarcomas combined, MPNST makes up between 5% and 10% of these cases, and represents approximately 0.02% of all cancers diagnosed.^[7][23]

The cancer can affect anyone, including older children and teenagers, but most people diagnosed with neurofibrosarcoma are between 20 and 40 years old. Some sources indicate that the condition typically affects people aged 30 to 50 years old.^[6][13] The rarity of this cancer means that many primary care doctors may never encounter a case during their careers, which is why getting specialized care is so important.

In the head and neck region specifically, neurofibrosarcoma is even more uncommon, accounting for only 8% to 16% of all cases of this cancer type. Most cases occur elsewhere in the body, particularly in the limbs.^[5]

Who Is at Risk?

The strongest known risk factor for developing neurofibrosarcoma is having a genetic condition called neurofibromatosis type 1 (NF1), also known as von Recklinghausen’s disease. This is an inherited disorder where benign tumors develop along nerves throughout the body. People with NF1 face a significantly higher risk of these benign tumors transforming into cancer.^[1]

The connection between NF1 and neurofibrosarcoma is substantial. Approximately 25% to 50% of all people diagnosed with neurofibrosarcoma also have neurofibromatosis type 1. Looking at it from the other direction, people with NF1 have an 8% to 13% lifetime risk of developing this cancer—much higher than the general population.^[7] Some studies indicate that up to 16% of people with neurofibromatosis eventually develop neurofibrosarcoma.^[1]

Previous radiation therapy is another risk factor. About 10% of people who develop MPNST have previously received radiation treatment for other medical conditions. The radiation exposure may contribute to the development of these tumors years later.^[13]

Additionally, people with a specific type of benign tumor called plexiform neurofibroma have an increased risk of developing MPNST. These plexiform neurofibromas themselves have about a 10% chance of becoming cancerous over a person’s lifetime.^[18]

What Causes Neurofibrosarcoma?

The exact cause of neurofibrosarcoma remains not fully understood, though researchers have identified several important factors. Studies have shown that genetics play a significant role in the formation of all soft tissue sarcomas, including neurofibrosarcoma.^[1]

The origin of these tumors can vary. Some develop directly from cells within peripheral nerves themselves. Others arise seemingly out of nowhere, called developing “de novo,” without any preceding condition. Still others result from the malignant transformation of previously benign neurofibromas that existed for years without causing problems.^[5]

In cases associated with neurofibromatosis type 1, scientists have identified genetic changes involving the NF1 gene located on chromosome 17. The loss or complete inhibition of this gene appears to be part of the process by which normal nerve sheath cells become cancerous. However, the fact that almost half of MPNST cases occur in people without NF1 suggests that other mechanisms are also at work.^[9]

Limited studies have also shown possible links between soft tissue sarcomas and other types of cancer, suggesting there may be shared risk factors or genetic susceptibilities that aren’t yet fully understood.^[1]

Recognizing the Symptoms

The symptoms of neurofibrosarcoma depend heavily on where the tumor is located and how large it has grown. Some people have no symptoms at all in the early stages, particularly when the tumors are small. As the cancer grows, symptoms become more noticeable.^[7]

The most common symptom is a growing lump or swelling under the skin. This lump may be painless initially, though many people do experience pain or soreness, especially as the tumor presses against nerves or muscles. The lumps can range in size from as small as a pea (about 2 centimeters) to as large as a grapefruit (about 10 centimeters).^[1][13]

When tumors press on nerves, they can cause several neurological symptoms. People may experience weakness when trying to move the affected body part. Paresthesia, which is an abnormal tingling or prickling sensation, is also common. Some people experience nerve loss, meaning they lose feeling or function in certain areas.^[1][13]

If the tumor affects the legs or arms, it may cause a limp or difficulty using the hands, feet, arms, or legs normally. The cancer can interfere with normal movement and coordination, making everyday activities challenging.^[1]

Because neurofibrosarcoma affects tissue that is elastic and easily moved, the tumors can exist for a long time before they’re diagnosed. This delay can be particularly problematic because the cancer is aggressive and benefits from early treatment.^[1]

How Doctors Diagnose the Condition

Diagnosing neurofibrosarcoma involves multiple steps and various tests. The process begins with a thorough physical examination and a detailed review of your medical history, including any family history of cancer or genetic conditions like neurofibromatosis.^[1]

A neurological exam is particularly important. During this examination, doctors assess your nervous system function in detail, looking for clues that might point toward a diagnosis of MPNST. This helps them gather information about how the tumor might be affecting your nerves.^[11]

Imaging tests create pictures of the inside of your body and are crucial for seeing the tumor’s size and location. Doctors typically order several types of scans. Magnetic resonance imaging (MRI) is one of the most valuable tools because it provides detailed images of soft tissues and nerves. Sometimes doctors use a specialized technique called magnetic resonance neurography for even more detailed nerve imaging.^[1][11]

Computed tomography (CT) scans may also be ordered to see the tumor from different angles and check whether the cancer has spread to other parts of the body. Positron emission tomography (PET) scans can help identify areas of active cancer growth throughout the body. For initial evaluation, a simple X-ray might be taken, though more detailed imaging usually follows.^[1][11]

A biopsy is essential for confirming the diagnosis. During this procedure, doctors remove a small sample of tissue from the tumor. This can be done using a needle inserted through the skin, or sometimes surgery is needed to obtain the sample. A specialist called a pathologist then examines the tissue under a microscope and performs additional tests to determine whether the tumor is cancerous and specifically whether it’s MPNST.^[1][11]

Blood tests, including a complete blood count, may be performed as part of the overall assessment, though they don’t diagnose MPNST directly. After all tests are completed, doctors can outline the best treatment options based on your specific situation.^[1]

Staging the Cancer

Once neurofibrosarcoma has been diagnosed, the tumor is given a “stage.” Staging helps doctors understand how far the cancer has spread and guides treatment decisions. The stages are usually labeled as stage I, stage II, stage III, or stage IV, with higher numbers indicating more advanced disease.^[1]

Neurofibrosarcoma may be classified as localized, meaning it hasn’t spread beyond the nerve tissue where it started. Alternatively, it may be metastatic, meaning it has spread to other parts of the body. When MPNST spreads, it most commonly goes to the lungs. Fortunately, most cases of neurofibrosarcoma remain localized, which generally means better treatment outcomes.^[1]

The stage helps doctors predict how the condition is likely to respond to treatment and informs decisions about which treatments will be most appropriate. It also provides important information about prognosis, though many individual factors affect each person’s outlook.^[1]

Treatment Approaches

Surgery is the main treatment for neurofibrosarcoma. The goal is to remove the entire tumor along with some surrounding healthy tissue, called taking a margin. Removing this margin helps ensure that any cancer cells not visible to the naked eye are also removed, which can reduce the risk of the cancer returning.^[1]

Sometimes surgery alone isn’t sufficient or possible. When tumors are very large, located in difficult areas, or cannot be safely removed completely, other treatments are used. Depending on the size and location of the tumor, doctors might need to remove part of a limb, though in most cases they can perform limb-sparing procedures to avoid amputation.^[1]

Chemotherapy uses anti-cancer drugs to destroy cancer cells. It may be given before surgery to shrink the tumor, making it easier to remove. This is called neoadjuvant treatment. Chemotherapy can also be given after surgery to kill any remaining cancer cells, or when the cancer has spread to other parts of the body. However, malignant peripheral nerve sheath tumors don’t always respond well to chemotherapy, so its effectiveness varies.^[1][14]

Radiation therapy uses high-energy radiation beams to destroy cancer cells. Like chemotherapy, it can be given before surgery to shrink tumors or after surgery to kill remaining cancer cells. Radiation is particularly useful for intermediate and high-grade tumors and when the surgical margins are close, meaning the tumor came close to the edge of what was removed.^[1][14]

Some patients may be offered opportunities to participate in clinical trials. These research studies investigate new drugs, treatments, or care approaches that might improve outcomes for people with neurofibrosarcoma. Targeted therapy and immunotherapy are being studied as potential new treatment options.^[13]

What Happens After Treatment

After treatment, regular follow-up appointments are essential. You’ll typically have these appointments for several years, following a schedule provided by your healthcare team. These visits usually include a chance to discuss any symptoms you’re experiencing, an examination to look for signs of cancer returning, and sometimes imaging tests.^[23]

Unfortunately, neurofibrosarcoma can come back even after successful treatment. This is called recurrence, and it can happen in the same location (local recurrence) or in other parts of the body. Sometimes microscopic traces of cancer remain after surgery, which is enough for the tumor to regrow. If the cancer returns, it can be more difficult to treat, though surgery and other treatments may still be options depending on the situation.^[23]

How the Disease Affects the Body

Neurofibrosarcoma creates changes in how your body normally functions because it affects the peripheral nervous system. Peripheral nerves are essential for voluntary movement and sensation, so when tumors grow along these nerves, they interfere with these crucial functions.^[1]

At a cellular level, the disease begins when Schwann cells, which form the protective covering around nerve fibers, start growing abnormally. Normally, these cells grow in a controlled way to maintain and repair the nerve sheath. In neurofibrosarcoma, genetic mutations cause these cells to multiply rapidly and uncontrollably, forming tumors.^[6]

As tumors grow, they can press on the nerves themselves, causing pain and interfering with nerve signals. This pressure can lead to the weakness, numbness, and loss of function that people experience. The elastic nature of nerve tissue means tumors can grow quite large before causing obvious symptoms, which partly explains why diagnosis is sometimes delayed.^[1]

Because neurofibrosarcoma is a type of sarcoma—cancer that grows in soft tissues like muscle, fat, tendons, or nerves—it can also invade surrounding tissues. The cancer can spread along nerve pathways extensively, and in some cases, cancer cells break away and travel through blood or lymph vessels to form new tumors in distant parts of the body, particularly the lungs.^[7]

In people with neurofibromatosis type 1, the transformation from benign tumors to cancer involves specific genetic changes. The pathways that normally control cell growth and division become disrupted, allowing cells to grow out of control. Understanding these mechanisms is important for researchers working to develop better treatments.^[7]